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Abstract: Cervical radiculopathy is characterized by compression of
the roots of the nerve. When conservative treatment fails and symp-
toms persist or increase in severity, surgical treatment is considered.
Anterior cervical discectomy with or without fusion is regarded as the
standard treatment for cervical disk herniation. Recently, there is an
evolving trend in spinal surgery towards less invasive techniques.
Nucleoplasty is a minimally invasive technique in which radio-
frequency technology is used for percutaneous decompression. During
the last years nucleoplasty has been proven to be a safe and effective
treatment to alleviate radiculopathy, caused by a contained disk
herniation. Nucleoplasty is usually performed on an outpatient basis
and is associated with a fast recovery time. This paper will describe the
preoperative and postoperative management of cervical nucleoplasty
as well as the surgical technique, accompanied by a video.
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INDICATIONS
Strict selection criteria of patients are essential for
successful treatment. The ideal selection criteria are patients
with symptomatic single-level contained cervical disk
herniation’s (CDH) and minimally degenerated disks.
Contraindications are sequestered disk fragments, stenosis
of the neural foramen or spinal canal, primary or metastatic
malignancy, discitis, calciﬁed disks, osteophytes, severe
degenerative disk disease with > 50% loss of disk height,
previous operations of the intervertebral disk at the same
level, anticoagulant therapy, impaired coagulation and
pregnancy. Preoperative screening starts with an x-ray of the
cervical spine to exclude osteophytes, possible misalignment
of the vertebrae, facet arthropathy, stenosis of the canal, and
fracture. Magnetic Resonance imaging (MRi) with T1-and
T2-weighting sequences is performed before the PCN
procedure to conﬁrm the level of the CDH (See Fig. 1).
OPERATING ROOM SET-UP
Instruments/Materials Required
 X-ray permeable table
 Intraoperative ﬂuoroscopy (C-arm)
 ArthroCare introducer cannula, 19 G
 ArthroCare Coblator IQ SpineWand, surgical device
with integrated cable
 ArthroCare Coablator IQ controller with foot control
Preoperative Preparation
 One hour before the PCN antibiotic therapy is
administered with Cefazoline.
 The patient is placed in a supine position on an x-ray
permeable table with head slightly hyper extended.
 The neck is sterilized with a Chloorhexidine 0.5% in
alcohol 70% solution.
 The draping starts along the patient’s neck using a 40×40
cm2 Steri-Drape with a 10×12.5 cm2 adhesive aperture
and then drapes are placed to create aseptic conditions.
 The patient is treated under local anesthesia and the
procedure is performed under a light intravenous
sedation with low dose Remifentanil intravenously.
 A facial mask (oxygen 40%, air 60%) is used. This mask
also creates a better breathing space for the patients’
comfort during the procedure.
 The patient is monitored during the procedure. ECG,
blood pressure and oxygen saturation are measured.
 The intraoperative ﬂuoroscopy (C-arm) is positioned on
the opposite of the surgeon to obtain anteroposterior
(AP), lateral and oblique view.
SURGICAL PROCEDURE
Please see the Supplemental Digital Content for the
accompanying video of the procedure (Supplemental
Digital Content 1, http://links.lww.com/CLINSPINE/A42).
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Step 1: Marking
The intervertebral space of the CDH is detected with
a trocar/needle under ﬂuoroscopic view. The procedure is
always performed from the right side to prevent puncture
of the esophagus. The surgeon keeps the sternocleido-
mastoid muscle laterally and the trachea medially and the
position of the carotid artery is localized. The introducer
cannula (19-G, 7.6 cm) is then inserted under a 45-degree
angle medially to the sternocleidomastoid muscle and
vessels through an anterior lateral approach, and stopped
when the annulus/ nucleus junction is reached. The tip of
the cannula stylet is aimed for the center of the nucleus in
both the coronal and sagittal planes. AP and lateral x-ray
monitoring views conﬁrm the precise positioning of the
cannula within the nucleus.
Step 2: Insert the Spine Wand
The stylet is withdrawn from the introducer cannula
and replaced with the Spine Wand Co-ablation needle
(see Fig. 2). This device is advanced until its tip extends
approximately 5mm beyond the tip of the cannula, in order
to ensure that the active portion of the wand is deployed in
the center or posterior third of the nucleus pulposus.
Step 3: Ablation
A short initial motoric stimulation (0.5 s) is per-
formed upon wand insertion in the most distal position to
ensure correct placement; if stimulation or movement is
detected, the device will be repositioned. As the device is
drawn back out through the disk, 3 ablation cycles of 10
seconds each will be performed, rotating the device tip 360
degrees each time to form 3 consecutive pockets within the
disk. The ﬁrst coablation cycle is performed most poste-
rior in the disk and conﬁrmed by ﬂuoroscopy, the second
coablation cycle is performed 3–5 mm more proximal and
the third another 3–5 mm more proximal. These 3 ablation
cycles lead to a volumetric reduction of the tissue of the
nucleus pulposus, resulting in decompression of the her-
niated disk. The coablation procedure should be painless;
if any pain is experienced during coablation the position of
the needle is reassessed by ﬂuoroscopy. If the pain persists
despite optimal position of the needle the procedure is
cancelled.
Step 4: Closure
The 1-mm skin incision is closed with a plaster.
POSTOPERATIVE PROTOCOL
Postoperatively, antibiotic prophylaxis with a ceph-
alosporin is administered to all the patients. To prevent
neck edema, patients are treated with a coldpack during
1 hour. Postoperatively, patients are observed during
3 hours bed rest. If necessary, conservative therapies
(physical therapy, nonsteroidal anti-inﬂammatory drugs
and analgesics according to the World Health Organ-
isation pain ladder) are prescribed. In our practice, no
collars are applied postoperatively. In the absence of
complications, patients are discharged on the same day of
the procedure. Heavy lifting, forward bending, twisting of
the neck, and severe physical activities are not permitted
during the ﬁrst 2 weeks after the procedure. After 2 weeks
the patient is allowed to return to sedentary or light work.
In our practice, a follow-up phone call is performed by a
nurse, trained in Pain Medicine, 48 hours after the pro-
cedure. During this consult pain measured by VAS-scores
of the affected arm, neck, shoulder and hand, complica-
tions (hoarseness and dysphagia), and use pain medication
are evaluated. If necessary, pain medication is adjusted.
After 6–8 weeks the patient has a control appointment at
our clinic to evaluate the ﬁnal results.
FIGURE 1. Sagital and axial magnetic resonance imaging of the bulging disk at level C6–C7 left.
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COMPLICATIONS
As PCN is performed through needle coablation
and no structures are ligated, complications rarely occur
and data on these complications are scarce. A recent meta-
analysis pooled results of 6 studies compromising 638
patients.1 Among these patients the complication rate was
0.8% which included one complication because of instrument
failure. Spondylodiscitis is another reported complication,2
which can be dealt with antimicrobial therapy One case of
inferior thyroid artery injury is reported.3
PEARLS AND PITFALLS
 PCN, compared with surgical treatment, is a less
invasive technique which is performed under local
anesthetics on an outpatient basis.
 The procedure is proved to be a safe technique
when performed in an experienced center with a
dedicated team.
 Before placement of the needle the position of the
carotid artery and trachea should be marked to avoid
complications. For this reason, the procedure is always
performed from the right side to avoid perforation of
the esophagus.
 Localizing the exact level by ﬂuoroscopy en placement
of the needle in tunnel vision is one of the keys of a
successful procedure.
 During treatment of the CDH in the lower cervical
region, ﬂuoroscopic visualization can be impaired by
over projection of the shoulders. Some traction at the
arms can resolve this problem.
 Selecting the correct CDHs for PCN is key for a successful
outcome.
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FIGURE 2. A, The position of the needle. B, The fluoroscopy.
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